The TM Ardis Interbody System is indicated for use with autogenous bone graft as an intervertebral body fusion device at one or two contiguous levels in the lumbosacral region in the treatment of degenerative disc disease with up to Grade 1 spondylolisthesis or retrolisthesis at the involved levels. The TM Ardis Implant features an updated, anatomical shape which allows the implant to be inserted into the disc space more easily.
More Articles on Zimmer:
Device Makers Get Boost After Biomet Posts Strong 4Q Financials
43 Orthopedic & Spine Devices Receive FDA Clearance in May
12 Spine Device & Implant Launches
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.